{"id":"https://openalex.org/W4290434264","doi":null,"title":"Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.","display_name":"Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.","publication_year":1987,"publication_date":"1987-01-01","ids":{"openalex":"https://openalex.org/W4290434264","mag":"94267655","pmid":"https://pubmed.ncbi.nlm.nih.gov/3331040"},"language":"en","primary_location":{"id":"pmid:3331040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3331040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian journal of infectious diseases. Supplementum","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037299967","display_name":"J Del Valle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Del Valle","raw_affiliation_strings":["Department of Medicine, Hospital \"1. de Octubre\", Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Hospital \"1. de Octubre\", Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013675766","display_name":"Ariel Rub\u00e9n Lindo Noriega","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A R Noriega","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082633570","display_name":"F Sanz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Sanz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048340343","display_name":"A P Revilla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A P Revilla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5081141002","display_name":"J R Otero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J R Otero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.51007401,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"52","issue":null,"first_page":"20","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7827000021934509,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.7827000021934509,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.2012999951839447,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imipenem-cilastatin","display_name":"imipenem/cilastatin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/septicemia","display_name":"septicemia","score":0.9200000166893005},{"id":"https://openalex.org/keywords/bacterial-sepsis","display_name":"bacterial sepsis","score":0.7170000076293945},{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/carbapenems","display_name":"carbapenems","score":0.8259999752044678},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6570000052452087},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9079999923706055},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9459999799728394},{"id":"https://openalex.org/keywords/bacteremia","display_name":"bacteremia","score":0.6690000295639038},{"id":"https://openalex.org/keywords/cardiovascular-infections","display_name":"cardiovascular infections","score":0.46399998664855957},{"id":"https://openalex.org/keywords/urological-infections","display_name":"urological infections","score":0.8939999938011169},{"id":"https://openalex.org/keywords/intra-abdominal-infection","display_name":"intra-abdominal infection","score":0.9750000238418579}],"concepts":[{"id":"https://openalex.org/C2781255259","wikidata":"https://www.wikidata.org/wiki/Q418201","display_name":"Imipenem/cilastatin","level":5,"score":0.9814300537109375},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.951621413230896},{"id":"https://openalex.org/C2777437143","wikidata":"https://www.wikidata.org/wiki/Q418201","display_name":"Cilastatin","level":5,"score":0.9132590293884277},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7850246429443359},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.6709246039390564},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5863097906112671},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5778287649154663},{"id":"https://openalex.org/C2780998478","wikidata":"https://www.wikidata.org/wiki/Q5374236","display_name":"Empirical treatment","level":3,"score":0.4762972891330719},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.42790815234184265},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.23035725951194763},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.06411930918693542},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.058706581592559814}],"mesh":[{"descriptor_ui":"D000077728","descriptor_name":"Cilastatin, Imipenem Drug Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001424","descriptor_name":"Bacterial Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013845","descriptor_name":"Thienamycins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015377","descriptor_name":"Cilastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015378","descriptor_name":"Imipenem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3331040","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3331040","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian journal of infectious diseases. Supplementum","raw_type":"Clinical Trial"},{"id":"mag:94267655","doi":null,"is_oa":false,"landing_page_url":"http://europepmc.org/abstract/MED/3331040","pdf_url":null,"source":{"id":"https://openalex.org/S200495913","display_name":"Scandinavian Journal of Infectious Diseases","issn_l":"0036-5548","issn":["0036-5548","1651-1980","2374-4235","2374-4243"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Scandinavian Journal of Infectious Diseases","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W146797565","https://openalex.org/W2320143188","https://openalex.org/W2418227250","https://openalex.org/W2263262639","https://openalex.org/W2267155920","https://openalex.org/W2169261995","https://openalex.org/W2420099256","https://openalex.org/W2419419113","https://openalex.org/W2415344929","https://openalex.org/W1999267898"],"abstract_inverted_index":{"The":[0,27,123],"clinical":[1],"efficacy":[2],"and":[3,24,54,156,172],"safety":[4],"of":[5,11,29,57,85,88,97,102,140,178],"imipenem/cilastatin":[6,30,141,167],"in":[7,21,61,94,100,131,148,151,162],"the":[8,55,63,86,98,103,109],"empirical":[9,174],"treatment":[10,92,113,142,177],"adult":[12],"non-immunocompromised":[13],"patients":[14,39,106,112,133,153],"with":[15,80],"severe":[16],"bacterial":[17,125],"septicemia":[18],"was":[19,31,168],"studied":[20],"a":[22,169],"prospective":[23],"open":[25],"trial.":[26],"dosage":[28],"500":[32],"mg":[33],"q":[34],"6":[35],"h.":[36],"Of":[37],"58":[38],"included,":[40],"41":[41,104],"were":[42,59,76,127,160],"evaluable":[43,105],"for":[44,83,176],"efficacy.":[45],"In":[46,108,165],"those":[47],"patients,":[48],"35":[49],"had":[50,114],"chronic":[51],"underlying":[52],"diseases":[53],"foci":[56,150],"bacteremia":[58],"identified":[60],"37;":[62],"most":[64],"common":[65],"ones":[66],"being":[67],"cardiovascular,":[68],"urologic":[69],"or":[70],"intraabdominal":[71],"infections.":[72],"All":[73],"isolated":[74],"organisms":[75],"sensitive":[77,145],"to":[78,115,120,146],"imipenem":[79,147],"an":[81],"MIC":[82],"90%":[84],"strains":[87,126],"1":[89],"mg/l.":[90],"Imipenem/cilastatin":[91],"resulted":[93],"rapid":[95],"control":[96],"infections":[99],"39":[101],"(95.5%).":[107],"remaining":[110],"two":[111],"be":[116],"prematurely":[117],"discontinued":[118],"due":[119],"adverse":[121,158],"effects.":[122],"causative":[124],"eradicated":[128],"from":[129],"blood":[130],"all":[132],"who":[134],"received":[135],"more":[136],"than":[137],"one":[138],"day":[139],"but":[143],"persisted":[144],"peripheral":[149],"five":[152],"(17%).":[154],"Clinical":[155],"laboratory":[157],"reactions":[159],"noted":[161],"seven":[163],"patients.":[164],"conclusion,":[166],"well":[170],"tolerated":[171],"effective":[173],"drug":[175],"septicemia.":[179]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-08-07T00:00:00"}